WINDTREE THERAPEUTICS INC /DE/ (WINTW)

Latest Insider Confidence Score

2025Q4

50.0
Bullish

Company insider confidence (by quarter)

2010Q3 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
LPH Investments Ltd — 46,232,085 Nov 21, 2017
China Cardiovascular Focus Ltd — 8,063,861 Dec 26, 2018
Lee's Pharmaceutical International Ltd — 8,063,861 Dec 26, 2018
Panacea Venture Healthcare Fund I, L.P. — 4,527,345 Dec 31, 2018
Ivy Blue Holdings Ltd — 4,336,790 Dec 31, 2018

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 14, 2024 PELLETIER SAUNDRA L Director Neutral 52.5 - 0.00% ✗ -
Aug 14, 2024 Latkin Jed Director Neutral 52.5 - 0.00% ✗ -
Jul 22, 2024 Jul 24, 2024 Simonson Steven SVP, Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jul 22, 2024 Jul 24, 2024 Fraser Craig CEO Neutral 52.5 - 0.00% ✗ -
Sep 27, 2023 Sep 28, 2023 Fraser Craig CEO Buy 82.5 +2,500 4.51% ✗ $2.5K
Sep 26, 2023 Sep 27, 2023 Fraser Craig CEO Buy 82.5 +2,500 4.73% ✗ $2.3K
Sep 5, 2023 McAndrew Jamie VP, Controller, & CAO Neutral 52.5 - 0.00% ✗ -
Aug 23, 2023 Aug 29, 2023 Geffken Daniel E. Director Neutral 90.0 +2,033 1431.69% ✗ -
Aug 23, 2023 Aug 25, 2023 Williams Leslie J. Director Neutral 90.0 +2,033 2033.00% ✗ -
Aug 23, 2023 Aug 25, 2023 Strobeck Mark Director Neutral 90.0 +2,300 100.00% ✗ -
Aug 23, 2023 Aug 25, 2023 SCOTT ROBERT A Director Neutral 90.0 +2,033 2033.00% ✗ -
Aug 23, 2023 Aug 25, 2023 Simonson Steven SVP, Chief Medical Officer Neutral 90.0 +15,867 1004.88% ✗ -
Aug 23, 2023 Aug 25, 2023 Curtis Eric COO Neutral 90.0 +14,667 1170.55% ✗ -
Aug 23, 2023 Aug 25, 2023 Fraser Craig CEO Neutral 90.0 +45,867 654.03% ✗ -
Jun 28, 2023 Strobeck Mark Director Neutral 52.5 - 0.00% ✗ -
Apr 26, 2023 Apr 27, 2023 Fraser Craig CEO Buy 90.0 +1,497 27.14% ✗ $2.6K
Apr 25, 2023 Apr 26, 2023 Fraser Craig CEO Buy 90.0 +1,315 31.30% ✗ $2.5K
Feb 28, 2023 Mar 2, 2023 Simonson Steven SVP, Chief Medical Officer Neutral 27.5 -100 -5.96% ✗ -
Feb 28, 2023 Mar 2, 2023 Fraser Craig CEO Neutral 27.5 -334 -7.36% ✗ -
Feb 28, 2023 Mar 2, 2023 Curtis Eric COO Neutral 27.5 -99 -7.32% ✗ -
Feb 28, 2023 Mar 2, 2023 CARMAN DIANE SVP & General Counsel Neutral 27.5 -99 -7.47% ✗ -
Feb 22, 2023 Feb 23, 2023 Huang James Director Neutral 52.5 - 0.00% ✗ -
Feb 3, 2023 Tattory John A CFO Neutral 52.5 - 0.00% ✗ -
Jul 27, 2022 Jul 27, 2022 Fraser Craig CEO Buy 77.5 +2,500 1.12% ✗ $949.8
Jul 26, 2022 Jul 26, 2022 Hamill John P. CFO Buy 82.5 +3,000 4.30% ✗ $1.1K
Jul 26, 2022 Jul 26, 2022 Fraser Craig CEO Buy 77.5 +2,500 1.13% ✗ $935
Jun 30, 2022 Jul 5, 2022 Fraser Craig CEO Buy 77.5 +4,500 2.07% ✗ $1.9K
Jun 29, 2022 Jun 30, 2022 Fraser Craig CEO Buy 82.5 +7,000 3.33% ✗ $2.9K
Jun 7, 2022 Jun 9, 2022 Williams Leslie J. Director Neutral 90.0 +5,000 100.00% ✗ -
Jun 7, 2022 Jun 9, 2022 SCOTT ROBERT A Director Neutral 90.0 +5,000 100.00% ✗ -
Jun 7, 2022 Jun 9, 2022 Huang James Director Neutral 55.0 +5,000 0.19% ✗ -
Jun 7, 2022 Jun 9, 2022 Geffken Daniel E. Director Neutral 90.0 +5,000 241.66% ✗ -
Mar 16, 2022 Mar 17, 2022 Fraser Craig CEO Buy 67.5 +2,000 0.96% ✗ $2K
Mar 15, 2022 Mar 15, 2022 Simonson Steven SVP, Chief Medical Officer Buy 85.0 +5,000 6.34% ✗ $5K
Mar 15, 2022 Mar 15, 2022 Fraser Craig CEO Buy 77.5 +3,000 1.46% ✗ $2.9K
Mar 4, 2022 Mar 7, 2022 Simonson Steven SVP, Chief Medical Officer Neutral 90.0 +66,300 526.44% ✗ -
Mar 4, 2022 Mar 7, 2022 Hamill John P. CFO Neutral 90.0 +66,300 1894.29% ✗ -
Mar 4, 2022 Mar 7, 2022 Fraser Craig CEO Neutral 90.0 +166,900 435.71% ✗ -
Mar 4, 2022 Mar 7, 2022 Curtis Eric COO Neutral 90.0 +66,300 5135.55% ✗ -
Mar 4, 2022 Mar 7, 2022 CARMAN DIANE SVP & General Counsel Neutral 90.0 +66,300 100.00% ✗ -
May 20, 2020 Jan 10, 2022 Center Laboratories, Inc. 10% Owner Buy 17.5 -2,257,490 -47.67% ✗ $2.4M
May 20, 2020 Jan 10, 2022 Bioengine Capital Inc. 10% Owner Sell 17.5 -4,735,666 -100.00% ✗ $1.6M
Nov 19, 2021 Nov 22, 2021 Fraser Craig CEO Buy 77.5 +930 2.49% ✗ $1.5K
Nov 18, 2021 Nov 18, 2021 Fraser Craig CEO Buy 82.5 +930 2.55% ✗ $1.5K
Oct 22, 2021 Oct 25, 2021 Fraser Craig CEO Buy 85.0 +3,000 8.97% ✗ $5.7K
Oct 19, 2021 Oct 19, 2021 Huang James Director Buy 82.5 +50,000 1.94% ✗ $95.1K
Oct 19, 2021 Oct 19, 2021 Fraser Craig CEO Buy 85.0 +3,000 9.85% ✗ $5.7K
Jul 1, 2021 Jul 6, 2021 CARMAN DIANE SVP & General Counsel Neutral 52.5 - 0.00% ✗ -
Jul 6, 2021 CARMAN DIANE SVP & General Counsel Neutral 52.5 - 0.00% ✗ -
Jun 15, 2021 Jun 17, 2021 Huang James Director Neutral 52.5 - 0.00% ✗ -
Jun 15, 2021 Jun 17, 2021 Geffken Daniel E. Director Neutral 52.5 - 0.00% ✗ -
Apr 16, 2021 Apr 20, 2021 Fraser Craig CEO Buy 82.5 +1,000 3.40% ✗ $2.1K
Apr 16, 2021 Apr 19, 2021 Hamill John P. CFO Buy 90.0 +1,000 40.00% ✗ $2.1K
Apr 15, 2021 Apr 19, 2021 Fraser Craig CEO Buy 82.5 +1,000 3.52% ✗ $2.2K
Apr 7, 2021 Apr 8, 2021 Curtis Eric COO Buy 90.0 +791 158.20% ✗ $2K
Apr 6, 2021 Apr 7, 2021 Fraser Craig CEO Buy 77.5 +500 1.79% ✗ $1.3K
Apr 5, 2021 Apr 6, 2021 Fraser Craig CEO Buy 82.5 +1,000 3.71% ✗ $2.6K
Apr 1, 2021 Apr 5, 2021 Fraser Craig CEO Buy 77.5 +500 1.89% ✗ $1.2K
Mar 31, 2021 Apr 2, 2021 Huang James Director Buy 92.5 +150,000 6.18% ✗ $354K
Mar 31, 2021 Mar 31, 2021 Fraser Craig CEO Buy 77.5 +500 1.93% ✗ $1.2K
Mar 25, 2021 Mar 25, 2021 Simonson Steven SVP, Chief Medical Officer Buy 90.0 +1,500 13.52% ✗ $4.9K
Mar 25, 2021 Mar 25, 2021 Hamill John P. CFO Buy 90.0 +1,500 150.00% ✗ $4.9K
Mar 25, 2021 Mar 25, 2021 Fraser Craig CEO Buy 85.0 +1,500 6.14% ✗ $4.9K
Feb 3, 2021 Feb 9, 2021 SCOTT ROBERT A Director Neutral 52.5 - 0.00% ✗ -
Feb 9, 2021 SCOTT ROBERT A Director Neutral 52.5 - 0.00% ✗ -
Feb 3, 2021 Feb 5, 2021 PEACOCK BRUCE Director Neutral 52.5 - 0.00% ✗ -
Feb 3, 2021 Feb 5, 2021 Huang James Director Neutral 52.5 - 0.00% ✗ -
Feb 3, 2021 Feb 5, 2021 Geffken Daniel E. Director Neutral 52.5 - 0.00% ✗ -
Feb 3, 2021 Feb 5, 2021 Schreiber Brian D Director Neutral 52.5 - 0.00% ✗ -
Feb 3, 2021 Feb 5, 2021 Joseph Mahady M Director Neutral 52.5 - 0.00% ✗ -
Feb 3, 2021 Feb 5, 2021 Leone John R Director Neutral 52.5 - 0.00% ✗ -
Feb 3, 2021 Feb 5, 2021 Williams Leslie J. Director Neutral 52.5 - 0.00% ✗ -
Feb 3, 2021 Feb 5, 2021 Loh Evan Director Neutral 52.5 - 0.00% ✗ -
Feb 5, 2021 Williams Leslie J. Director Neutral 52.5 - 0.00% ✗ -
Feb 5, 2021 Loh Evan Director Neutral 52.5 - 0.00% ✗ -
Jan 22, 2021 Jan 26, 2021 Simonson Steven SVP, Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 22, 2021 Jan 26, 2021 Hamill John P. CFO Neutral 52.5 - 0.00% ✗ -
Jan 22, 2021 Jan 26, 2021 Fraser Craig CEO Neutral 52.5 - 0.00% ✗ -
Jan 22, 2021 Jan 26, 2021 Curtis Eric COO Neutral 52.5 - 0.00% ✗ -
Oct 28, 2020 Oct 29, 2020 Fraser Craig CEO Buy 77.5 +250 1.03% ✗ $1.6K
Oct 23, 2020 Oct 27, 2020 Huang James Director Buy 47.5 +1,000 0.04% ✗ $6.7K
Jun 4, 2020 Oct 26, 2020 Huang James Director Buy 95.0 +12,000 150.00% ✗ $87.9K
Oct 9, 2020 Oct 13, 2020 Fraser Craig CEO Buy 77.5 +250 1.04% ✗ $1.5K
Jul 29, 2020 Oct 9, 2020 Curtis Eric COO Neutral 52.5 - 0.00% ✗ -
Oct 7, 2020 Oct 9, 2020 Hamill John P. CFO Buy 90.0 +1,000 100.00% ✗ $5.3K
Oct 7, 2020 Oct 9, 2020 Fraser Craig CEO Buy 77.5 +250 1.06% ✗ $1.3K
Oct 8, 2020 Oct 9, 2020 Curtis Eric COO Buy 90.0 +500 100.00% ✗ $2.6K
Jul 20, 2020 Jul 22, 2020 Hamill John P. CFO Neutral 52.5 - 0.00% ✗ -
Jul 22, 2020 Hamill John P. CFO Neutral 52.5 - 0.00% ✗ -
Jun 3, 2020 Jun 5, 2020 Huang James Director Buy 72.5 +12,400 0.51% ✗ $90.8K
May 22, 2020 May 27, 2020 Templeton Mary B Esq SVP, Gen Counsel & Corp Sec Buy 90.0 +1,103 303.86% ✗ $8K
May 22, 2020 May 27, 2020 Tattory John A CFO Buy 82.5 +449 4.95% ✗ $3.3K
May 22, 2020 May 27, 2020 Simonson Steven SVP, Chief Medical Officer Buy 82.5 +517 4.89% ✗ $3.7K
May 22, 2020 May 27, 2020 Fraser Craig CEO Buy 86.3 +2,069 9.57% ✗ $15K
May 22, 2020 May 27, 2020 Schreiber Brian D Director Buy 91.3 +2,069 100.00% ✗ $15K
May 22, 2020 May 27, 2020 PEACOCK BRUCE Director Buy 91.3 +3,500 64.98% ✗ $25.4K
May 22, 2020 May 27, 2020 Joseph Mahady M Director Buy 91.3 +2,069 38.41% ✗ $15K
May 22, 2020 May 27, 2020 Leone John R Director Buy 91.3 +2,069 38.29% ✗ $15K
May 22, 2020 May 27, 2020 Huang James Director Buy 100.0 +275,862 12.90% ✗ $2M
May 22, 2020 May 27, 2020 Geffken Daniel E. Director Buy 91.3 +2,069 100.00% ✗ $15K